|
US6080216A
(en)
*
|
1998-04-22 |
2000-06-27 |
3M Innovative Properties Company |
Layered alumina-based abrasive grit, abrasive products, and methods
|
|
JPWO2005049622A1
(ja)
*
|
2003-11-19 |
2007-06-07 |
日本たばこ産業株式会社 |
5−5員縮合複素環化合物及びそのhcvポリメラーゼ阻害剤としての用途
|
|
US20070049593A1
(en)
*
|
2004-02-24 |
2007-03-01 |
Japan Tobacco Inc. |
Tetracyclic fused heterocyclic compound and use thereof as HCV polymerase inhibitor
|
|
CA2585113A1
(en)
*
|
2004-10-26 |
2006-05-04 |
Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa |
Tetracyclic indole derivatives as antiviral agents
|
|
US7795247B2
(en)
*
|
2004-10-26 |
2010-09-14 |
Istituto Di Ricerche Di Biologia Molecolare P. Angeletti Spa |
Tetracyclic indole derivatives as antiviral agents
|
|
US7659263B2
(en)
|
2004-11-12 |
2010-02-09 |
Japan Tobacco Inc. |
Thienopyrrole compound and use thereof as HCV polymerase inhibitor
|
|
CA2606195C
(en)
|
2005-05-02 |
2015-03-31 |
Merck And Co., Inc. |
Hcv ns3 protease inhibitors
|
|
US8278322B2
(en)
|
2005-08-01 |
2012-10-02 |
Merck Sharp & Dohme Corp. |
HCV NS3 protease inhibitors
|
|
GB0518390D0
(en)
*
|
2005-09-09 |
2005-10-19 |
Angeletti P Ist Richerche Bio |
Therapeutic compounds
|
|
US7399758B2
(en)
*
|
2005-09-12 |
2008-07-15 |
Meanwell Nicholas A |
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
|
|
US7473688B2
(en)
*
|
2005-09-13 |
2009-01-06 |
Bristol-Myers Squibb Company |
Indolobenzazepine HCV NS5B inhibitors
|
|
WO2007092000A1
(en)
*
|
2006-02-06 |
2007-08-16 |
Bristol-Myers Squibb Company |
Inhibitors of hcv replication
|
|
US7456165B2
(en)
|
2006-02-08 |
2008-11-25 |
Bristol-Myers Squibb Company |
HCV NS5B inhibitors
|
|
GB0608928D0
(en)
*
|
2006-05-08 |
2006-06-14 |
Angeletti P Ist Richerche Bio |
Therapeutic agents
|
|
GB0609492D0
(en)
|
2006-05-15 |
2006-06-21 |
Angeletti P Ist Richerche Bio |
Therapeutic agents
|
|
CN101443336B
(zh)
*
|
2006-05-17 |
2012-07-04 |
百时美施贵宝公司 |
环丙基稠合的[吲哚]并[苯并氮杂*]hcv ns5b抑制剂
|
|
US7521443B2
(en)
*
|
2006-05-17 |
2009-04-21 |
Bristol-Myers Squibb Company |
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
|
|
US7456166B2
(en)
*
|
2006-05-17 |
2008-11-25 |
Bristol-Myers Squibb Company |
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
|
|
US7521441B2
(en)
*
|
2006-05-22 |
2009-04-21 |
Bristol-Myers Squibb Company |
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
|
|
WO2007140200A2
(en)
*
|
2006-05-25 |
2007-12-06 |
Bristol-Myers Squibb Company |
Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors
|
|
CN101490054B
(zh)
*
|
2006-05-25 |
2012-05-16 |
百时美施贵宝公司 |
环丙基稠合的吲哚并苯并氮杂*hcv ns5b抑制剂
|
|
US7452876B2
(en)
|
2006-06-08 |
2008-11-18 |
Bristol-Myers Squibb Company |
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
|
|
GB0612423D0
(en)
|
2006-06-23 |
2006-08-02 |
Angeletti P Ist Richerche Bio |
Therapeutic agents
|
|
DK2041156T3
(en)
|
2006-07-13 |
2014-02-24 |
Achillion Pharmaceuticals Inc |
4-AMINO-4-OXOBUTANOYL Peptides AS INHIBITORS OF VIRUS REPLICATION
|
|
PE20081113A1
(es)
*
|
2006-07-20 |
2008-10-03 |
Genelabs Tech Inc |
Inhibidores virales policiclicos
|
|
EP2076278B1
(en)
|
2006-10-24 |
2015-05-06 |
Merck Sharp & Dohme Corp. |
Macrocyclic HCV NS3 protease inhibitors
|
|
EP2079480B1
(en)
|
2006-10-24 |
2013-06-05 |
Merck Sharp & Dohme Corp. |
Hcv ns3 protease inhibitors
|
|
WO2008051475A2
(en)
|
2006-10-24 |
2008-05-02 |
Merck & Co., Inc. |
Hcv ns3 protease inhibitors
|
|
BRPI0718161A2
(pt)
|
2006-10-27 |
2013-11-26 |
Merck & Co Inc |
Composto, composição farmacêutica, e, uso do composto.
|
|
EP2083844B1
(en)
|
2006-10-27 |
2013-11-27 |
Merck Sharp & Dohme Corp. |
Hcv ns3 protease inhibitors
|
|
EP2121707B1
(en)
*
|
2006-12-20 |
2012-12-05 |
Istituto di Ricerche di Biologia Molecolare P. Angeletti S.R.L. |
Antiviral indoles
|
|
GB0625349D0
(en)
|
2006-12-20 |
2007-01-31 |
Angeletti P Ist Richerche Bio |
Therapeutic compounds
|
|
GB0625345D0
(en)
|
2006-12-20 |
2007-01-31 |
Angeletti P Ist Richerche Bio |
Therapeutic compounds
|
|
RU2009127855A
(ru)
*
|
2006-12-22 |
2011-01-27 |
Шеринг Корпорейшн (US) |
4,5 циклоаннелированные производные индола для лечения или предотвращения вируса гепатита с (hcv) и родственных вирусных инфекций
|
|
CA2673254C
(en)
|
2006-12-22 |
2013-09-10 |
Schering Corporation |
4,5-ring annulated indole derivatives for treating or preventing of hcv and related viral infections
|
|
US8268803B2
(en)
|
2006-12-22 |
2012-09-18 |
Merck Sharp & Dohme Corp. |
5, 6-ring annulated indole derivatives and use thereof
|
|
US7541351B2
(en)
*
|
2007-01-11 |
2009-06-02 |
Bristol-Myers Squibb Company |
Compounds for the treatment of hepatitis C
|
|
US7541352B2
(en)
*
|
2007-02-02 |
2009-06-02 |
Bristol-Myers Squibb Company |
Compounds for the treatment of hepatitis C
|
|
US7517872B2
(en)
*
|
2007-02-22 |
2009-04-14 |
Bristol-Myers Squibb Company |
Compounds for the treatment of hepatitis C
|
|
WO2008106130A2
(en)
*
|
2007-02-26 |
2008-09-04 |
Achillion Pharmaceuticals, Inc. |
Tertiary amine substituted peptides useful as inhibitors of hcv replication
|
|
DK2144604T3
(da)
|
2007-02-28 |
2011-10-17 |
Conatus Pharmaceuticals Inc |
Fremgangsmåder til behandling af kronisk viral hepatitis C under anvendelse af RO 113-0830
|
|
US7998951B2
(en)
*
|
2007-03-05 |
2011-08-16 |
Bristol-Myers Squibb Company |
HCV NS5B inhibitors
|
|
CN101679437B
(zh)
*
|
2007-03-13 |
2013-04-17 |
百时美施贵宝公司 |
环丙基稠合的吲哚并苯并氮杂*hcv ns5b抑制剂
|
|
US7538102B2
(en)
*
|
2007-03-14 |
2009-05-26 |
Bristol-Myers Squibb Company |
Compounds for the treatment of Hepatitis C
|
|
US7547690B2
(en)
*
|
2007-03-14 |
2009-06-16 |
Bristol-Myers Squibb Company |
Compounds for the treatment of Hepatitis C
|
|
US7521444B2
(en)
*
|
2007-03-14 |
2009-04-21 |
Bristol-Myers Squibb Company |
Compounds for the treatment of hepatitis C
|
|
US7541353B2
(en)
*
|
2007-03-14 |
2009-06-02 |
Bristol-Myers Squibb Company |
Compounds for the treatment of hepatitis C
|
|
US7538103B2
(en)
*
|
2007-03-15 |
2009-05-26 |
Bristol-Myers Squibb Company |
Compounds for the treatment of hepatitis C
|
|
US7964580B2
(en)
|
2007-03-30 |
2011-06-21 |
Pharmasset, Inc. |
Nucleoside phosphoramidate prodrugs
|
|
EP2494991A1
(en)
|
2007-05-04 |
2012-09-05 |
Vertex Pharmaceuticals Incorporated |
Combination therapy for the treatment of HCV infection
|
|
CN101754970B
(zh)
*
|
2007-07-17 |
2013-07-10 |
P.安杰莱蒂分子生物学研究所 |
用于治疗丙型肝炎的大环吲哚衍生物
|
|
US8927569B2
(en)
|
2007-07-19 |
2015-01-06 |
Merck Sharp & Dohme Corp. |
Macrocyclic compounds as antiviral agents
|
|
US7652004B2
(en)
*
|
2007-08-09 |
2010-01-26 |
Bristol-Myers Squibb Company |
Compounds for the treatment of hepatitis C
|
|
US8143243B2
(en)
*
|
2007-08-09 |
2012-03-27 |
Bristol-Myers Squibb Company |
Compounds for the treatment of hepatitis C
|
|
US7642251B2
(en)
*
|
2007-08-09 |
2010-01-05 |
Bristol-Myers Squibb Company |
Compounds for the treatment of hepatitis C
|
|
WO2009032116A1
(en)
|
2007-08-29 |
2009-03-12 |
Schering Corporation |
2, 3-substituted indole derivatives for treating viral infections
|
|
KR20100065167A
(ko)
|
2007-08-29 |
2010-06-15 |
쉐링 코포레이션 |
바이러스 감염 치료용 2,3-치환된 아자인돌 유도체
|
|
KR20100067652A
(ko)
|
2007-08-29 |
2010-06-21 |
쉐링 코포레이션 |
치환된 인돌 유도체 및 이의 사용방법
|
|
AU2008295483B2
(en)
*
|
2007-08-29 |
2013-11-21 |
Merck Sharp & Dohme Corp. |
Tetracyclic indole derivatives and their use for treating or preventing viral infections
|
|
MX2010005356A
(es)
|
2007-11-16 |
2010-05-27 |
Schering Corp |
Derivados de indol 3-heterociclico sustituidos y metodos de uso de los mismos.
|
|
CA2705587A1
(en)
|
2007-11-16 |
2009-05-22 |
Schering Corporation |
3-aminosulfonyl substituted indole derivatives and methods of use thereof
|
|
US8124601B2
(en)
|
2007-11-21 |
2012-02-28 |
Bristol-Myers Squibb Company |
Compounds for the treatment of Hepatitis C
|
|
US8129367B2
(en)
*
|
2007-11-21 |
2012-03-06 |
Bristol-Myers Squibb Company |
Compounds for the treatment of Hepatitis C
|
|
CN103483251A
(zh)
|
2007-12-19 |
2014-01-01 |
贝林格尔.英格海姆国际有限公司 |
病毒聚合酶抑制剂
|
|
PL2238142T3
(pl)
|
2007-12-24 |
2012-11-30 |
Janssen R&D Ireland |
Makrocykliczne indole jako inhibitory wirusa zapalenia wątroby typu C
|
|
US8147818B2
(en)
*
|
2008-02-13 |
2012-04-03 |
Bristol-Myers Squibb Company |
Hepatitis C virus inhibitors
|
|
EP2280978B1
(en)
*
|
2008-03-27 |
2013-04-24 |
Bristol-Myers Squibb Company |
Pyrrolidine fused indolobenzadiazepine hcv ns5b inhibitors
|
|
EP2268643B1
(en)
*
|
2008-03-27 |
2014-08-06 |
Bristol-Myers Squibb Company |
Dioxolane and dioxolanone fused indolobenzadiazepine hcv ns5b inhibitors
|
|
AU2009228337A1
(en)
*
|
2008-03-27 |
2009-10-01 |
Bristol-Myers Squibb Company |
Compounds for the treatment of hepatitis C
|
|
US8431568B2
(en)
|
2008-03-27 |
2013-04-30 |
Bristol-Myers Squibb Company |
Aromatic heterocyclic fused indolobenzadiazepine HCV NS5B inhibitors
|
|
EP2271345B1
(en)
|
2008-04-28 |
2015-05-20 |
Merck Sharp & Dohme Corp. |
Hcv ns3 protease inhibitors
|
|
US8133884B2
(en)
*
|
2008-05-06 |
2012-03-13 |
Bristol-Myers Squibb Company |
Compounds for the treatment of hepatitis C
|
|
US8173621B2
(en)
|
2008-06-11 |
2012-05-08 |
Gilead Pharmasset Llc |
Nucleoside cyclicphosphates
|
|
WO2009152200A1
(en)
|
2008-06-13 |
2009-12-17 |
Schering Corporation |
Tricyclic indole derivatives and methods of use thereof
|
|
TWI454476B
(zh)
|
2008-07-08 |
2014-10-01 |
Tibotec Pharm Ltd |
用作c型肝炎病毒抑制劑之巨環吲哚衍生物
|
|
ME02132B
(me)
|
2008-07-22 |
2014-08-22 |
Merck Sharp & Dohme |
Kombinacije makrocikličnog jedinjenja hinoksalina koje je inhibitor hcv ns3 proteaze sa drugim hcv sredstvima
|
|
CA2733743A1
(en)
|
2008-08-11 |
2010-02-18 |
Glaxosmithkline Llc |
Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases
|
|
HRP20171398T1
(hr)
|
2008-08-11 |
2017-11-03 |
Glaxosmithkline Llc |
Novi derivati adenina
|
|
UA103195C2
(uk)
|
2008-08-11 |
2013-09-25 |
Глаксосмитклайн Ллк |
Похідні пурину для застосування у лікуванні алергій, запальних та інфекційних захворювань
|
|
UY32099A
(es)
|
2008-09-11 |
2010-04-30 |
Enanta Pharm Inc |
Inhibidores macrocíclicos de serina proteasas de hepatitis c
|
|
US8614180B2
(en)
*
|
2008-12-10 |
2013-12-24 |
Achillion Pharmaceuticals, Inc. |
4-amino-4-oxobutanoyl peptides as inhibitors of viral replication
|
|
BRPI0922913A2
(pt)
*
|
2008-12-10 |
2015-08-18 |
Achillion Pharmaceuticals Inc |
Análogos cíclicos de peptídeo 4-amino-4-oxobutanoil inibidores de replicação viral
|
|
MX2011006647A
(es)
*
|
2008-12-22 |
2011-07-12 |
Hoffmann La Roche |
Compuestos heterociclicos antivirales.
|
|
EA019341B1
(ru)
|
2008-12-23 |
2014-02-28 |
Джилид Фармассет, Ллс. |
Фосфорамидаты нуклеозидов
|
|
EP2376514A2
(en)
|
2008-12-23 |
2011-10-19 |
Pharmasset, Inc. |
Nucleoside analogs
|
|
BRPI0923815A2
(pt)
|
2008-12-23 |
2015-07-14 |
Pharmasset Inc |
Síntese de nucleosídeos de purina
|
|
CA2750227A1
(en)
|
2009-01-07 |
2010-07-15 |
Scynexis, Inc. |
Cyclosporine derivative for use in the treatment of hcv and hiv infection
|
|
EP2396329B1
(en)
*
|
2009-02-11 |
2014-10-29 |
Bristol-Myers Squibb Company |
Compounds for the treatment of hepatitis c
|
|
US8143244B2
(en)
*
|
2009-02-26 |
2012-03-27 |
Bristol-Myers Squibb Company |
Cyclopropyl fused indolobenzazepine HCV NS5B inhibitors
|
|
MY169311A
(en)
|
2009-03-27 |
2019-03-21 |
Merck Sharp & Dohme |
Inhibitors of hepatitis c virus replication
|
|
US20190127365A1
(en)
|
2017-11-01 |
2019-05-02 |
Merck Sharp & Dohme Corp. |
Inhibitors of hepatitis c virus replication
|
|
TW201100398A
(en)
*
|
2009-03-31 |
2011-01-01 |
Arqule Inc |
Substituted indolo-pyridinone compounds
|
|
TWI598358B
(zh)
|
2009-05-20 |
2017-09-11 |
基利法瑪席特有限責任公司 |
核苷磷醯胺
|
|
US8618076B2
(en)
|
2009-05-20 |
2013-12-31 |
Gilead Pharmasset Llc |
Nucleoside phosphoramidates
|
|
WO2011014487A1
(en)
|
2009-07-30 |
2011-02-03 |
Merck Sharp & Dohme Corp. |
Hepatitis c virus ns3 protease inhibitors
|
|
JP2013519644A
(ja)
|
2010-02-10 |
2013-05-30 |
グラクソスミスクライン エルエルシー |
プリン誘導体およびそれらの薬学的使用
|
|
BR112012018904A2
(pt)
|
2010-02-10 |
2020-09-01 |
Glaxosmithkline Llc |
composto, adjuvante de vacina, composições imunogênica, de vacina e farmacêutica, e uso de um composto"
|
|
KR20130008040A
(ko)
*
|
2010-03-09 |
2013-01-21 |
머크 샤프 앤드 돔 코포레이션 |
융합된 트리시클릭 실릴 화합물 및 바이러스성 질환의 치료를 위한 그의 사용 방법
|
|
LT2609923T
(lt)
|
2010-03-31 |
2017-09-11 |
Gilead Pharmasset Llc |
(s)-izopropilo 2-(((s)-(perfluorfenoksi)(fenoksi)fosforil)amino)-propanoato kristalinimo būdas
|
|
PL3290428T3
(pl)
|
2010-03-31 |
2022-02-07 |
Gilead Pharmasset Llc |
Tabletka zawierająca krystaliczny (S)-2-(((S)-(((2R,3R,4R,5R)-5-(2,4-diokso-3,4-dihydropirymidyn-1(2H)-ylo)-4-fluoro-3-hydroksy-4-metylotetrahydrofuran-2-ylo)metoksy)(fenoksy)fosforylo)amino)propanian izopropylu
|
|
TW201136945A
(en)
|
2010-03-31 |
2011-11-01 |
Pharmasset Inc |
Purine nucleoside phosphoramidate
|
|
MX2012015198A
(es)
|
2010-06-24 |
2013-02-11 |
Janssen R & D Ireland |
Preparacion de acido 13-ciclohexil-3-metoxi-6-[metil-(2-{2-[metil- (sulfamoil)-amino]-etoxi}-etil)-carbomoil]-7h-indolo-[2,1-a]-[2]- benzazepin-10-carboxilico.
|
|
JP2013540122A
(ja)
|
2010-09-29 |
2013-10-31 |
メルク・シャープ・エンド・ドーム・コーポレイション |
縮合四環式化合物誘導体およびウィルス疾患治療のためのそれの使用方法
|
|
US8841275B2
(en)
|
2010-11-30 |
2014-09-23 |
Gilead Pharmasset Llc |
2′-spiro-nucleosides and derivatives thereof useful for treating hepatitis C virus and dengue virus infections
|
|
US8951964B2
(en)
|
2010-12-30 |
2015-02-10 |
Abbvie Inc. |
Phenanthridine macrocyclic hepatitis C serine protease inhibitors
|
|
CN103534256B
(zh)
|
2010-12-30 |
2016-08-10 |
益安药业 |
大环丙型肝炎丝氨酸蛋白酶抑制剂
|
|
WO2012122716A1
(en)
|
2011-03-17 |
2012-09-20 |
Merck Sharp & Dohme Corp. |
Tetracyclic xanthene derivatives and methods of use thereof for treatment of viral diseases
|
|
US10201584B1
(en)
|
2011-05-17 |
2019-02-12 |
Abbvie Inc. |
Compositions and methods for treating HCV
|
|
CA2840242C
(en)
|
2011-09-16 |
2019-03-26 |
Gilead Sciences, Inc. |
Methods for treating hcv
|
|
AU2013201406B2
(en)
|
2011-10-21 |
2014-10-02 |
Abbvie Ireland Unlimited Company |
Methods for treating HCV
|
|
US8492386B2
(en)
|
2011-10-21 |
2013-07-23 |
Abbvie Inc. |
Methods for treating HCV
|
|
AR088408A1
(es)
|
2011-10-21 |
2014-05-28 |
Abbvie Inc |
Metodos para el tratamiento de hcv
|
|
US8466159B2
(en)
|
2011-10-21 |
2013-06-18 |
Abbvie Inc. |
Methods for treating HCV
|
|
US8889159B2
(en)
|
2011-11-29 |
2014-11-18 |
Gilead Pharmasset Llc |
Compositions and methods for treating hepatitis C virus
|
|
US10202392B2
(en)
|
2012-04-26 |
2019-02-12 |
Francis Xavier Tavares |
Synthesis of lactams
|
|
BR112015000714A2
(pt)
*
|
2012-07-18 |
2017-06-27 |
Bristol Myers Squibb Holdings Ireland |
processos e intermediários para a preparação de (4bs,5ar)-12-ciclo-hexil-n-(n,n-dimetilsulfamoil)-3-metóxi-5a-((1r,5s)-3-metil-3,8-diazabiciclo[3.2.1]octano-8-carbonil)-4b,5,5a, 6-tetra-hidrobenzo [3,4]ciclopropa[5,6]azepino[1,2-a] indol-9-carboxamida
|
|
WO2014110687A1
(en)
|
2013-01-16 |
2014-07-24 |
Merck Sharp & Dohme Corp. |
Thiazolyl-substitued tetracyclic compounds and methods of use thereof for treatment of viral diseases
|
|
EP3650013A1
(en)
|
2013-01-31 |
2020-05-13 |
Gilead Pharmasset LLC |
Combination formulation of two antiviral compounds
|
|
WO2014121418A1
(en)
|
2013-02-07 |
2014-08-14 |
Merck Sharp & Dohme Corp. |
Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis c
|
|
WO2014121417A1
(en)
|
2013-02-07 |
2014-08-14 |
Merck Sharp & Dohme Corp. |
Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis c
|
|
WO2014121416A1
(en)
|
2013-02-07 |
2014-08-14 |
Merck Sharp & Dohme Corp. |
Tetracyclic heterocycle compounds and methods of use thereof for the treatment of hepatitis c
|
|
WO2014145600A1
(en)
|
2013-03-15 |
2014-09-18 |
Achillion Pharmaceuticals, Inc. |
Ach-0142684 sodium salt polymorphs, composition including the same, and method of manufacture thereof
|
|
WO2014145507A1
(en)
|
2013-03-15 |
2014-09-18 |
Achillion Pharmaceuticals, Inc. |
A process for making a 4-amino-4-oxobutanoyl peptide cyclic analogue, an inhibitor of viral replication, and intermediates thereof
|
|
MX2015013020A
(es)
|
2013-03-15 |
2016-06-10 |
Achillion Pharmaceuticals Inc |
Polimorfos de sovaprevir y metodos de fabricacion de los mismos.
|
|
SI3038601T1
(sl)
|
2013-08-27 |
2020-07-31 |
Gilead Pharmasset Llc |
Formulacija kombinacije dveh protivirusnih spojin
|
|
US20160257688A1
(en)
*
|
2013-10-24 |
2016-09-08 |
Francis Xavier Tavares |
Process for Synthesis of Lactams
|
|
WO2015103490A1
(en)
|
2014-01-03 |
2015-07-09 |
Abbvie, Inc. |
Solid antiviral dosage forms
|
|
JP6452711B2
(ja)
|
2014-02-20 |
2019-01-16 |
グラクソスミスクライン、インテレクチュアル、プロパティー、(ナンバー2)、リミテッドGlaxosmithkline Intellectual Property (No.2) Limited |
ヒトインターフェロンの誘導物質としてのピロロ[3,2]ピリミジン誘導体
|
|
US10584125B2
(en)
|
2014-11-13 |
2020-03-10 |
Glaxosmithkline Biologicals Sa |
Adenine derivatives which are useful in the treatment of allergic diseases or other inflammatory conditions
|
|
CR20180286A
(es)
|
2015-12-03 |
2018-07-16 |
Glaxosmithkline Ip Dev Ltd |
Dinucleotidos de purina cíclicos como moduladores de sting
|
|
EP3440072B1
(en)
|
2016-04-07 |
2020-01-29 |
GlaxoSmithKline Intellectual Property Development Ltd |
Heterocyclic amides useful as protein modulators
|
|
JP6746712B2
(ja)
|
2016-04-07 |
2020-08-26 |
グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドGlaxosmithkline Intellectual Property Development Limited |
タンパク質調節因子として有用な複素環式アミド
|
|
EA201892448A1
(ru)
|
2016-04-28 |
2019-06-28 |
Эмори Юниверсити |
Алкинсодержащие нуклеотидные и нуклеозидные терапевтические композиции и связанные с ними способы применения
|
|
US11472806B2
(en)
|
2017-05-12 |
2022-10-18 |
Domain Therapeutics |
Substituted heterocyclic compounds as allosteric modulators of group II metabotropic glutamate receptors
|
|
EP3692033A1
(en)
|
2017-10-05 |
2020-08-12 |
GlaxoSmithKline Intellectual Property Development Limited |
Modulators of stimulator of interferon genes (sting) useful in treating hiv
|
|
US11377440B2
(en)
|
2017-10-05 |
2022-07-05 |
Glaxosmithkline Intellectual Property Development Limited |
Modulators of stimulator of interferon genes (STING)
|
|
GB201807924D0
(en)
|
2018-05-16 |
2018-06-27 |
Ctxt Pty Ltd |
Compounds
|
|
US20220251079A1
(en)
|
2019-05-16 |
2022-08-11 |
Stingthera, Inc. |
Benzo[b][1,8]naphthyridine acetic acid derivatives and methods of use
|
|
EP3969438A1
(en)
|
2019-05-16 |
2022-03-23 |
Stingthera, Inc. |
Oxoacridinyl acetic acid derivatives and methods of use
|
|
GB201910304D0
(en)
|
2019-07-18 |
2019-09-04 |
Ctxt Pty Ltd |
Compounds
|
|
GB201910305D0
(en)
|
2019-07-18 |
2019-09-04 |
Ctxt Pty Ltd |
Compounds
|
|
WO2021119753A1
(en)
|
2019-12-18 |
2021-06-24 |
Ctxt Pty Limited |
Compounds
|
|
US12274700B1
(en)
|
2020-10-30 |
2025-04-15 |
Accencio LLC |
Methods of treating symptoms of coronavirus infection with RNA polymerase inhibitors
|